
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients
Daan Jan Willem Rauwerdink, Olivier J. van Not, Melissa de Meza, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2656-2656
Open Access | Times Cited: 4
Daan Jan Willem Rauwerdink, Olivier J. van Not, Melissa de Meza, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2656-2656
Open Access | Times Cited: 4
Showing 4 citing articles:
Cutaneous Side Effects of PD ‐1 Inhibitors: A Single‐Center Retrospective Study
Melánia Pozsgai, Udoh Frieda‐Rex Sebastian, Péter Oláh, et al.
International Journal of Dermatology (2025)
Open Access | Times Cited: 1
Melánia Pozsgai, Udoh Frieda‐Rex Sebastian, Péter Oláh, et al.
International Journal of Dermatology (2025)
Open Access | Times Cited: 1
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade
Gusztav Milotay, Martin Little, Robert Watson, et al.
Nature Medicine (2025)
Open Access
Gusztav Milotay, Martin Little, Robert Watson, et al.
Nature Medicine (2025)
Open Access
Overcoming Resistance Mechanisms to Melanoma Immunotherapy
David X. Zheng, David J. Bozym, Giuseppe Tarantino, et al.
American Journal of Clinical Dermatology (2024)
Closed Access | Times Cited: 3
David X. Zheng, David J. Bozym, Giuseppe Tarantino, et al.
American Journal of Clinical Dermatology (2024)
Closed Access | Times Cited: 3
Cytomegalovirus infection protects against metastatic melanoma and modulates oncological outcome and toxicity to checkpoint immunotherapy
Gusztav Milotay, Martin Little, Robert Watson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Gusztav Milotay, Martin Little, Robert Watson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access